Catabasis Pharmaceuticals Garners $8,000,000 Series A Round

  • Feed Type
  • Date
    12/13/2011
  • Company Name
    Catabasis Pharmaceuticals
  • Mailing Address
    One Kendall Square Bldg. 1400E Cambridge, MA 02139
  • Company Description
    At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.
  • Website
    http://www.catabasispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The new funding will be used to accelerate the development of CAT-2003, the company’s omega-3 conjugated compound for patients with severe hypertriglyceridemia.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Advanced Technology Ventures

By posting a comment, you agree to our terms and conditions.